Safety of strontium ranelate in prevention of postmenopausal bone loss - a double-blind, prospective, placebo-controlled study.

被引：0
|
作者：
Reginster, JY
Roux, C
Jupsin, I
Tupinon-Mathieu, I
Tsouderos, Y
机构：
[1] Univ Liege, Bone & Cartilage Metab Unit, Liege, Belgium
[2] Univ Liege, WHO, Collaborating Ctr Publ Hlth Aspects Osteoarticula, Liege, Belgium
[3] Univ Liege, Dept Epidemiol & Publ Hlth, Liege, Belgium
[4] Hop Cochin, Serv Rhumatol, F-75674 Paris, France
[5] Inst Rech Servier, Courbevoie, France
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 1999年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SA410
引用
收藏
页码：S412 / S412
页数：1
相关论文
共 50 条
  • [1] Role of the strontium ranelate in prevention of early postmenopausal bone loss: A double blind, prospective, randomized, placebo-controlled study.
    Reginster, JY
    Roux, C
    Tsourderos, Y
    Juspin, I
    [J]. ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S129 - S129
  • [2] Prevention of early postmenopausal bone loss by strontium ranelate: A randomised, two-year, double-blind, placebo-controlled trial.
    Reginster, JL
    Deroisy, R
    Tsouderos, Y
    Jupsin, I
    Roux, C
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S222 - S222
  • [3] TREATMENT OF POSTMENOPAUSAL BONE LOSS WITH IPRIFLAVONE - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
    AGNUSDEI, D
    BUFALINO, L
    GENNARI, C
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1994, 54 (04) : 359 - 359
  • [4] Prevention of postmenopausal bone loss with pulsed estrogen therapy by nasal route: A randomised double-blind, placebo-controlled study
    Christiansen, C
    Bagger, Y
    Chetaille, E
    Varin, C
    [J]. OSTEOPOROSIS INTERNATIONAL, 2002, 13
  • [5] A 152 PATIENT DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF CYCLICAL ETIDRONATE THERAPY FOR THE PREVENTION OF EARLY POSTMENOPAUSAL BONE LOSS
    HERD, RJM
    BLAKE, GM
    RYAN, PJ
    FOGELMAN, I
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1995, 10 : S153 - S153
  • [6] Prevention of postmenopausal bone loss with pulsed estrogen therapy by nasal route: A randomised double-blind, placebo-controlled study
    Christiansen, C
    Bagger, Y
    Chetaille, E
    Varin, C
    [J]. OSTEOPOROSIS INTERNATIONAL, 2002, 13 (06) : 520 - 520
  • [7] A double blind, placebo-controlled trial of ipriflavone for prevention of postmenopausal spinal bone loss
    Agnusdei, D
    Crepaldi, G
    Isaia, G
    Mazzuoli, G
    Ortolani, S
    Passeri, M
    Bufalino, L
    Gennari, C
    Camporeale, A
    Cepollaro, C
    Gonnelli, S
    Giannini, S
    Sartori, L
    Sciolla, A
    Minisola, S
    Pisani, D
    Ulivieri, FM
    Costi, D
    DallAglio, E
    Pedrazzoni, M
    Castiglione, GN
    Gardini, F
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1997, 61 (02) : 142 - 147
  • [8] A Double Blind, Placebo-Controlled Trial of Ipriflavone for Prevention of Postmenopausal Spinal Bone Loss
    D. Agnusdei
    G. Crepaldi
    G. Isaia
    G. Mazzuoli
    S. Ortolani
    M. Passeri
    L. Bufalino
    C. Gennari
    [J]. Calcified Tissue International , 1997, 61 : 142 - 147
  • [9] POSTMENOPAUSAL OSTEOPOROSIS - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
    STEVENSON, JC
    LEES, B
    ELLERINGTON, MC
    WHITCROFT, SIJ
    MARSH, MS
    WHITEHEAD, MI
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1992, 7 : S325 - S325
  • [10] EFFICACY AND SAFETY OF STRONTIUM RANELATE IN THE TREATMENT OF KNEE OSTEOARTHRITIS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED INTERNATIONAL TRIAL
    Reginster, J. Y.
    Chapurlat, R.
    Christiansen, C.
    Genant, H.
    Bellamy, N.
    Bensen, W.
    Navarro, F.
    Badurski, J.
    Nasonov, E.
    Chevalier, X.
    Sambrook, P. N.
    Cooper, C.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2011, 22 : S742 - S743
12345